Moria is a worldwide leader in the design, manufacture and distribution of ophthalmic surgery equipment and instruments for both refractive and reconstructive surgery.
Moria has been at the leading edge of eye surgery technolgy for almost two centuries as a result of its close relationships with surgeons.
Moria's growth strategy is twofold, relying on the launch of well-targeted new products to expand the current instrument range and the expansion of the single-use instrument line.
The original investment in Moria was made by Edmond de Rothschild Capital Partners in 2010, and is now managed by Bridgepoint Portfolio Services.
To learn more about the company, visit www.moria-surgical.com